Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-13-000964
Filing Date
2013-01-31
Accepted
2013-01-31 16:58:26
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K unigene_10ka2-123111.htm 10-K/A 2240998
2 EXHIBIT 23.1 ex23-1.htm EX-23.1 5178
3 EXHIBIT 23.2 ex23-2.htm EX-23.2 13906
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 14735
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 15231
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 6862
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 6821
14 EXHIBIT 101. unigene_10ka2-1231110.jpg GRAPHIC 31473
  Complete submission text file 0001437749-13-000964.txt   9257140

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS ugne-20111231.xml EX-101.INS 1900427
9 EXHIBIT 101.SCH ugne-20111231.xsd EX-101.SCH 30046
10 EXHIBIT 101.CAL ugne-20111231_cal.xml EX-101.CAL 34856
11 EXHIBIT 101.DEF ugne-20111231_def.xml EX-101.DEF 159822
12 EXHIBIT 101.LAB ugne-20111231_lab.xml EX-101.LAB 209172
13 EXHIBIT 101.PRE ugne-20111231_pre.xml EX-101.PRE 163054
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-16005 | Film No.: 13563331
SIC: 2833 Medicinal Chemicals & Botanical Products